<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05111717</url>
  </required_header>
  <id_info>
    <org_study_id>MSKU 02/VII</org_study_id>
    <nct_id>NCT05111717</nct_id>
  </id_info>
  <brief_title>The Effect of Desfluran On Global Dna Methylation</brief_title>
  <official_title>The Effect of Desfluran Administered in General Anesthesia On Global Dna Methylation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Muğla Sıtkı Koçman University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Muğla Sıtkı Koçman University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the molecular effect of desflurane on DNA by&#xD;
      measuring the global DNA methylation level in patients under going lumbar spinal stenosis&#xD;
      surgery under general anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Forty patients scheduled for lumbar spinal surgery will include in the study. Peripheral&#xD;
      venous blood samples will collect prior to the induction of anesthesia (T1) and after 120&#xD;
      minutes (T2). Anesthesia will maintaine with 40%-60% O2-air mixture and 6% desflurane. DNA&#xD;
      will obtain from blood samples with the help of DNA isolation kit and global DNA methylation&#xD;
      analysis will perform by ELISA method.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 17, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 25, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Global DNA methylation change 5 minutes before and 120 minutes after anesthesia induction in peripheral blood mononuclear cells</measure>
    <time_frame>5 minutes before induction of anesthesia ,120 minutes after the beginning of anesthesia</time_frame>
    <description>The global DNA methylation level will be measured 5 minutes before and 120 minutes after anesthesia induction.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>DNA Damage</condition>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <description>Peripheral venous blood samples will collected at two time points as follows: before the premedication and the induction of anesthesia (T₁): 120 minutes after the beginning of anesthesia (T₂). DNA will be obtained from blood samples , and global DNA methylation analysis will be done.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>Peripheral venous blood samplesof patients will collected at two time points as follows: before the premedication and the induction of anesthesia (T₁): 120 minutes after the beginning of anesthesia (T₂). Anesthesia maintenance will be provided with 40% O₂ and minimum alveolar concentration (MAC) in 60% air with 6% desflurane. DNA will be obtained from blood samples with the help of DNA isolation kit, and global DNA methylation analysis will performed by ELISA method.</description>
    <arm_group_label>group 1</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      peripheral venous blood sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with physical status I and II of the American Society of Anesthesiologists (ASA),&#xD;
        aged between 18-65 and scheduled for lumbar spinal surgery, which will take at least 120&#xD;
        minutes, will be included in the study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Ability to understand and willingness to sign an informed consent form&#xD;
&#xD;
          2. Elective lumbar spinal surgery that will take at least 120 minutes,&#xD;
&#xD;
          3. American Society of Anesthesiologists (ASA) physical status I and II&#xD;
&#xD;
          4. Be between the ages of 18 and 65&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with ASA physical status III or IV disease&#xD;
&#xD;
          2. Smoking or alcohol consumption&#xD;
&#xD;
          3. Chronic systemic disease (diabetes mellitus,chronic pulmonary disorders, chronic&#xD;
             kidney and liver disorders&#xD;
&#xD;
          4. recently received radiation, chemotherapy&#xD;
&#xD;
          5. malignancy&#xD;
&#xD;
          6. blood transfusion in operation&#xD;
&#xD;
          7. use of antioxidant supplements&#xD;
&#xD;
          8. have received general anesthesia in the last three months&#xD;
&#xD;
          9. Patients with known occupational exposures (operating room personnel, chemical plant&#xD;
             workers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Melike Korkmaz Toker, assoc.Prof</last_name>
    <phone>00905054747098</phone>
    <email>meltoker@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mugla Sıtkı Kocman University Training and research Hospital</name>
      <address>
        <city>Mugla</city>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Melike Korkmaz Toker, Assoc.Prof</last_name>
      <phone>00905054747098</phone>
      <email>meltoker@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Chowdhury B, Cho IH, Irudayaraj J. Technical advances in global DNA methylation analysis in human cancers. J Biol Eng. 2017 Mar 1;11:10. doi: 10.1186/s13036-017-0052-9. eCollection 2017. Review.</citation>
    <PMID>28261325</PMID>
  </reference>
  <reference>
    <citation>Jaloszyński P, Kujawski M, Wasowicz M, Szulc R, Szyfter K. Genotoxicity of inhalation anesthetics halothane and isoflurane in human lymphocytes studied in vitro using the comet assay. Mutat Res. 1999 Feb 19;439(2):199-206.</citation>
    <PMID>10023059</PMID>
  </reference>
  <reference>
    <citation>Bilban M, Jakopin CB, Ogrinc D. Cytogenetic tests performed on operating room personnel (the use of anaesthetic gases). Int Arch Occup Environ Health. 2005 Feb;78(1):60-4. Epub 2005 Feb 10.</citation>
    <PMID>15703947</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 17, 2021</study_first_submitted>
  <study_first_submitted_qc>October 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Muğla Sıtkı Koçman University</investigator_affiliation>
    <investigator_full_name>Melike Korkmaz Toker</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>Desflurane,</keyword>
  <keyword>DNA methylation</keyword>
  <keyword>epigenetics</keyword>
  <keyword>inhalation anesthetics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>via mail</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

